The Department Chair of Neurosciences at Cleveland Clinic was a leading part of the group of researchers that recently identified the new subtype of multiple sclerosis.
Cleveland Clinic
Latest Content
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Insights on Vibrance-2 Study Results of Alixorexton in Narcolepsy Type 2: Richard K. Bogan, MD, FCCP, FAASM
2
FDA and EMA Accepts Regulatory Applications for Cemdisiran in Generalized Myasthenia Gravis
3
FDA Clears Investigational New Drug Application for Remyelinating Agent PTD802 in Multiple Sclerosis
4
Once-Nightly Sodium Oxybate Meets Primary End Point in Phase 3 REVITALYZ Study for Idiopathic Hypersomnia
5